CClinicalTrials.gg
CompletedNCT03419780SMaRTBloodUpdated Nov 4, 2020Results posted

SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum Anemia

An interventional study of Blood Transfusion in Postpartum Anemia Nos, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-04.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

There is a paucity of data on management of non-acute postpartum anemia. Although blood transfusions were historically initiated with 2 units, the most recent recommendation from the American Association of Blood Banks is to begin with 1 unit. As no randomized controlled trials have been performed in obstetrics, the investigators propose a randomized, controlled trial in non-acute postpartum anemia comparing single- versus multiple-unit transfusion by total numbers of units transfused and maternal morbidity.

Read the detailed description

Postpartum hemorrhage (PPH), which accounts for 30% of all direct maternal deaths, is the single most important cause of maternal morbidity and mortality across the globe and is a focus of attention of national organizations such as the Council for Patient Safety in Women's Health in recent years. Yet, there remains a paucity of data on the appropriate management of non-acute postpartum anemia.

It is common practice in obstetrics to offer a transfusion of packed red blood cells (pRBCs) to women with a hemoglobin (Hb) value less than 7 g/dL (hematocrit less than 20%) and to symptomatic women with even higher hemoglobin levels. Although transfusions were historically initiated with 2 units of pRBCs, the most recent recommendation from the American Association of Blood Banks (AABB) for a stable patient is to begin with 1 unit and reassess. However, while surgical data has successfully demonstrated that liberal blood transfusion increases morbidity and mortality in comparison to restricted transfusion, no randomized controlled trials have been performed in obstetrics to demonstrate superiority of a single-unit transfusion protocol.

The investigators propose a randomized, controlled trial in non-acute postpartum anemia comparing single-unit versus multiple-unit transfusion by total numbers of units transfused and maternal morbidity at the University of Pennsylvania with the hypothesis that single-unit transfusions can reduce the number of units transfused without increasing maternal morbidity.

02

Conditions studied

  • Postpartum Anemia Nos

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women over 18
  • Willing and stable to give consent
  • > 6 hours postpartum from any mode of delivery
  • Determined by their physician to require blood transfusion either by:

    • Hb \<7g/dL OR
    • >7g/dL with any sign or symptom of anemia such as fatigue, dizziness, tachycardia, or hypotension
  • Agreed to accept blood transfusion
  • No contraindications to blood transfusion

Exclusion criteria

Exclusion Criteria:

  • hemoglobinopathies
  • patients with an ejection fraction \<35%
  • Hb \<5 g/dL
  • HR > 130 bpm, BP \< 80/40
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • Active comparator
    Single-Unit Blood Transfusion Protocol

    In this arm, patients receive a 1 unit pRBC transfusion with the plan for post-transfusion blood count at 4-6 hours post-transfusion and clinical reassessment.

    Biological: Blood Transfusion

  • Active comparator
    Multiple-Unit Blood Transfusion Protocol

    In this arm, patients receive 2 units of pRBCs, followed by 4-6 hour post-transfusion blood count and clinical reassessment.

    Biological: Blood Transfusion

Interventions

  • BiologicalBlood Transfusion

    Patients are randomized to receive 1 or 2 units of packed red blood cells for initial transfusion.

05

What researchers measure

Primary outcomes

  1. Total Number of Units Transfused

    To determine if there is a difference between single-unit and multiple-unit transfusion protocols in total number of units transfused

    Time frame: From randomization until discharge from admission for delivery, an average of 2-3 days

Secondary outcomes

  1. Length of Stay

    To determine if there is a difference between single-unit and multiple-unit transfusion protocols in length of stay in days

    Time frame: From randomization until discharge from admission for delivery, an average of 2-3 days

  2. Number of Participants Exclusively Breastfeeding at 4-9 Weeks Postpartum

    To determine if there is a difference between single-unit and multiple-unit transfusion protocols in exclusive breastfeeding rates at 4-9 weeks postpartum.

    Time frame: At 4-9 weeks after randomization

  3. Rate of Depression

    • To determine if there is a difference between single-unit and multiple-unit transfusion protocols in Edinburgh Postnatal Depression Scale score at 4-9 weeks postpartum. EPDS scores range from 0-30, with higher scores (particularly above 10) are indicative of depression.

    Time frame: 4-9 weeks after randomization

  4. Rate of Fatigue

    • To determine if there is a difference between single-unit and multiple-unit transfusion protocols in Multidimensional Fatigue Inventory scores at 4-9 weeks postpartum. This score ranges from 0-140 with higher scores indicating worse fatigue.

    Time frame: 4-9 weeks after randomization

  5. Maternal Attachment Inventory Scores

    • To determine if there is a difference between single-unit and multiple-unit transfusion protocols in Maternal Attachment Inventory scores at 4-9 weeks postpartum. The possible range of scores is 26-104. Higher scores indicate higher maternal attachment to the infant.

    Time frame: 4-9 weeks after randomization

  6. Infection Rate

    Development of any deep or superficial infection

    Time frame: From randomization until 4-9 week postpartum visit

06

Results

Posted Nov 4, 2020

Participant flow

Participant flow — Overall Study
MilestoneSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Started3333
Completed3333
Not completed00

Outcome measures

PrimaryTotal Number of Units Transfused

To determine if there is a difference between single-unit and multiple-unit transfusion protocols in total number of units transfused

Time frame:
From randomization until discharge from admission for delivery, an average of 2-3 days
Reported as:
Mean · units of blood
Total Number of Units Transfused
units of bloodSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Total Number of Units Transfused1.2 ± 0.52.1 ± 0.4
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · t-test, 2 sided · p = <0.001
SecondaryLength of Stay

To determine if there is a difference between single-unit and multiple-unit transfusion protocols in length of stay in days

Time frame:
From randomization until discharge from admission for delivery, an average of 2-3 days
Reported as:
Median · Days
Length of Stay
DaysSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Length of Stay3.1 (2.5 to 3.8)3.4 (2.4 to 4.1)
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · Wilcoxon (Mann-Whitney) · p = 0.79
SecondaryNumber of Participants Exclusively Breastfeeding at 4-9 Weeks Postpartum

To determine if there is a difference between single-unit and multiple-unit transfusion protocols in exclusive breastfeeding rates at 4-9 weeks postpartum.

Time frame:
At 4-9 weeks after randomization
Reported as:
Count of participants · Participants
Number of Participants Exclusively Breastfeeding at 4-9 Weeks Postpartum
ParticipantsSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Number of Participants Exclusively Breastfeeding at 4-9 Weeks Postpartum1615
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · Chi-squared · p = 0.89
SecondaryRate of Depression

• To determine if there is a difference between single-unit and multiple-unit transfusion protocols in Edinburgh Postnatal Depression Scale score at 4-9 weeks postpartum. EPDS scores range from 0-30, with higher scores (particularly above 10) are indicative of depression.

Time frame:
4-9 weeks after randomization
Reported as:
Median · score on a scale
Rate of Depression
score on a scaleSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Rate of Depression4 (1 to 11)5.5 (2 to 8)
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · Wilcoxon (Mann-Whitney) · p = 0.34
SecondaryRate of Fatigue

• To determine if there is a difference between single-unit and multiple-unit transfusion protocols in Multidimensional Fatigue Inventory scores at 4-9 weeks postpartum. This score ranges from 0-140 with higher scores indicating worse fatigue.

Time frame:
4-9 weeks after randomization
Reported as:
Median · score on a scale
Rate of Fatigue
score on a scaleSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Rate of Fatigue44 (34 to 55)53 (38 to 70)
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · Wilcoxon (Mann-Whitney) · p = 0.13
SecondaryMaternal Attachment Inventory Scores

• To determine if there is a difference between single-unit and multiple-unit transfusion protocols in Maternal Attachment Inventory scores at 4-9 weeks postpartum. The possible range of scores is 26-104. Higher scores indicate higher maternal attachment to the infant.

Time frame:
4-9 weeks after randomization
Reported as:
Median · score on a scale
Maternal Attachment Inventory Scores
score on a scaleSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Maternal Attachment Inventory Scores104 (102 to 104)104 (102 to 104)
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · Wilcoxon (Mann-Whitney) · p = 0.55
SecondaryInfection Rate

Development of any deep or superficial infection

Time frame:
From randomization until 4-9 week postpartum visit
Reported as:
Number · participants
Infection Rate
participantsSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Infection Rate21
Statistical analysis
  • Single-Unit Blood Transfusion Protocol vs Multiple-Unit Blood Transfusion Protocol · Chi-squared · p = 1.00

Adverse events

Collected over Randomization until the time of the postpartum visit which occurred between 4 and 9 weeks after delivery.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Single-Unit Blood Transfusion Protocol0/33 (0%)0/33 (0%)0/33 (0%)
Multiple-Unit Blood Transfusion Protocol0/33 (0%)0/33 (0%)1/33 (3%)
Most frequent other events
Most frequent other events
EventSingle-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion Protocol
Unrelated transfer to the ICUPregnancy, puerperium and perinatal conditions0/331/33

Baseline characteristics

Age, Continuous
Age, Continuous(years)Single-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion ProtocolTotal
Mean29 ± 629 ± 629 ± 6
Sex: Female, Male
Sex: Female, Male(Participants)Single-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion ProtocolTotal
Female333366
Male000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Single-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion ProtocolTotal
Hispanic or Latino112
Not Hispanic or Latino323264
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Single-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion ProtocolTotal
American Indian or Alaska Native000
Asian314
Native Hawaiian or Other Pacific Islander000
Black or African American262450
White4711
More than one race000
Unknown or Not Reported011
Hemoglobin level at randomization
Hemoglobin level at randomization(g/dL)Single-Unit Blood Transfusion ProtocolMultiple-Unit Blood Transfusion ProtocolTotal
Mean6.8 ± 0.67.0 ± 0.66.9 ± 0.6
07

Study locations

1 site
  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
08

References and documents

Publications

  • Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5. PubMed 34932836 ↗
  • Hamm RF, Perelman S, Wang EY, Levine LD, Srinivas SK. Single-unit vs multiple-unit transfusion in hemodynamically stable postpartum anemia: a pragmatic randomized controlled trial. Am J Obstet Gynecol. 2021 Jan;224(1):84.e1-84.e7. doi: 10.1016/j.ajog.2020.07.007. Epub 2020 Jul 9. PubMed 32652065 ↗

Study documents

  • Informed consent form · Jan 15, 2019
  • Protocol and statistical analysis plan · Feb 15, 2018

Documents are hosted by the registry — open the source record to download them.

09

Registry details

Key details

Study ID
NCT03419780
Lead sponsor
University of Pennsylvania
Responsible party
Sponsor
First posted
Feb 5, 2018
Start date
Mar 1, 2018
Primary completion
Jun 1, 2020
Completion
Jun 1, 2020
Results posted
Nov 4, 2020
Last update
Nov 4, 2020

Study contacts

Sindhu K Srinivas, MD MSCE
principal investigator · University of Pennsylvania

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion